These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 11923230)

  • 1. Assessment of the impact of vision impairment.
    Weih LM; Hassell JB; Keeffe J
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):927-35. PubMed ID: 11923230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of participation in activities of daily living in people with impaired vision.
    Lamoureux EL; Hassell JB; Keeffe JE
    Am J Ophthalmol; 2004 Feb; 137(2):265-70. PubMed ID: 14962415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
    Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of a visual impairment questionnaire in measuring cataract surgery outcomes.
    Pesudovs K; Caudle LE; Rees G; Lamoureux EL
    J Cataract Refract Surg; 2008 Jun; 34(6):925-33. PubMed ID: 18498997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1001-6. PubMed ID: 17325138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
    du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Vision Impairment for Children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis.
    Cochrane GM; Marella M; Keeffe JE; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1632-40. PubMed ID: 21178144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the need for low vision rehabilitation services.
    O'Connor PM; Lamoureux EL; Keeffe JE
    Br J Ophthalmol; 2008 Feb; 92(2):252-5. PubMed ID: 18227205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the severity of distance and near-vision impairment on depression and vision-specific quality of life in older people living in residential care.
    Lamoureux EL; Fenwick E; Moore K; Klaic M; Borschmann K; Hill K
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4103-9. PubMed ID: 19357359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vision-specific distress and depressive symptoms in people with vision impairment.
    Rees G; Tee HW; Marella M; Fenwick E; Dirani M; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2891-6. PubMed ID: 20164466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
    Nutheti R; Keeffe JE; Shamanna BR; Nirmalan PK; Krishnaiah S; Thomas R
    Ophthalmology; 2007 Aug; 114(8):1552-7. PubMed ID: 17678693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER.
    Broman AT; Munoz B; West SK; Rodriguez J; Sanchez R; Snyder R; Klein R
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):606-13. PubMed ID: 11222517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire.
    Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3253-61. PubMed ID: 16877389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision and quality of life: the development of a utility measure.
    Misajon R; Hawthorne G; Richardson J; Barton J; Peacock S; Iezzi A; Keeffe J
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4007-15. PubMed ID: 16249474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK
    Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy.
    Owsley C; McGwin G; Scilley K; Kallies K
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):528-35. PubMed ID: 16431946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of the Melbourne low-vision ADL index: a measure of vision disability.
    Haymes SA; Johnston AW; Heyes AD
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1215-25. PubMed ID: 11328730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.